跳至主要内容
临床试验/NCT04242212
NCT04242212Unknown不适用

A Prospective, Comparative Study of Clinical Outcomes Following Clinic-based Versus Self-use of Medication Abortion Using a Misoprostol-only Regimen

Ipas1 个研究点 分布在 1 个国家目标入组 4,000 人开始时间: 2019年5月19日最近更新:
适应症

试验速览

阶段
不适用
发起方
Ipas
入组人数
4,000
试验地点
1
主要终点
Need for additional treatment to complete abortion

研究概览

简要总结

The goal of the study is to determine whether important clinical outcomes differ among women who access a misoprostol-only medication abortion regimen from a patent medicine vendor when compared with those who access it from a clinic.

详细描述

Medication abortion with a misoprostol-only regimen within the first 10 weeks of pregnancy is safe and effective. Investigators aim to assess whether self-use of early (<9 weeks) medication abortion using a misoprostol-only regimen results in non-inferior rates of clinical outcomes when compared with clinic-based provision of medication abortion.

The investigators will prospectively recruit women who obtain misoprostol from patent medicine vendors and clinics. Follow-up will occur by telephone during three phone calls within 45 days of the first dose of misoprostol.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
15 Years 至 49 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Purchased a misoprostol-only abortion regimen at a PMV or from a clinic
  • Be at least 15 years of age
  • Have a known LMP of less than 9 weeks
  • No contraindications to medical abortion
  • Willing and able to give informed consent
  • Have a mobile phone of which they are the independent user or be willing to be followed-up in person
  • Willing to be contacted with questions about her abortion by telephone at 1-3, 10-29 and 30-45 days following initial contact.

排除标准

  • Contraindications to misoprostol
  • Age <15 or >49

结局指标

主要结局

Need for additional treatment to complete abortion

时间窗: Final assessment at 45 days following misoprostol

The primary outcome of the study will be the need for additional treatment to complete the abortion (either aspiration or repeated misoprostol \>3 doses) following a woman taking the medication abortion pills.

次要结局

  • Serious complications/ morbidity(Final assessment at 45 days following misoprostol)

研究者

发起方
Ipas
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study of Clinic-based vs. Self-use of a... | 临床试验